Back
NovaBay Pharmaceuticals 10K Form
Sell
45
NBY
NovaBay Pharmaceuticals
Last Price:
0.77
Seasonality Move:
-8.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NBY News And Ratings
See the #1 stock for the next 7 days that we like better than NBY
NBY Financial Statistics
Sales & Book Value
Annual Sales: | $14.73M |
---|---|
Cash Flow: | $-580K |
Price / Cash Flow: | 0 |
Annual Sales: | $-0.46 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -48.14620 |
---|---|
Net Income (TTM): | $-10.66M |
Gross Margin: | $7.9M |
Return on Equity: | -288.89% |
Return on Assets: | -113.02% |
NovaBay Pharmaceuticals Earnings Forecast
Key NovaBay Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 21 years for NBY is 53.61%.
- The Selling, General & Administrative Expenses for NBY have been equal to 87.12% of Gross Profit Margin.
- The Research & Development expenses have been 0.46% of Revenue.
- The Net Earning history of NBY is -65.46% of Total Revenues.
- Per Share Earnings over the last 21 years have been positive in 11 years.
NovaBay Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYAM |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | NBY |
CUSIP: | 66987P |
Website: | novabay.com |
Debt
Debt-to-Equity Ratio: | -1.13 |
---|---|
Current Ratio: | 0.62 |
Quick Ratio: | 0.36 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
NBY Technical Analysis vs Fundamental Analysis
Sell
45
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a Sell
The current NovaBay Pharmaceuticals [NBY] share price is $0.76. The Score for NBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.